Incyte (INCY) Capital Expenditures (2010 - 2026)
Incyte (INCY) reported Capital Expenditures of $12.41 million for Q2 2026, down 34.9% from $19.07 million a year earlier but up 21.7% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Capital Expenditures (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Incyte's Capital Expenditures came in at $59.24 million, up 32.2% year-over-year; for FY2025, it was $58.87 million, down 31.8% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $86.26 million in FY2024 (+165.5%), $32.49 million in FY2023 (-58.3%), $77.83 million in FY2022 (-57.0%) and $181.01 million in FY2021 (-3.4%).
- Five-year quarterly Capital Expenditures spans a low of $2.27 million in Q4 2023 and a high of $54.14 million in Q2 2024.
- Year over year, Capital Expenditures gained in four of the last eight quarters, with growth averaging 110.0%.
- The high point for year-over-year Capital Expenditures in five years was Q4 2024 (growth of 666.8%); the low point was Q4 2023 (a decline of 89.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $10.2 million (Q1 2026), $21.88 million (Q4 2025) and $14.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn | 12.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.41 Mn |
| Mar 31, 2026 | 10.20 Mn |
| Dec 31, 2025 | 21.88 Mn |
| Sep 30, 2025 | 14.75 Mn |
| Jun 30, 2025 | 19.07 Mn |
| Mar 31, 2025 | 3.17 Mn |
| Dec 31, 2024 | 17.38 Mn |
| Sep 30, 2024 | 5.19 Mn |
| Jun 30, 2024 | 54.14 Mn |
| Mar 31, 2024 | 9.55 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 10.98 Mn |
| Jun 30, 2023 | 7.34 Mn |
| Mar 31, 2023 | 11.91 Mn |
| Dec 31, 2022 | 21.27 Mn |
| Sep 30, 2022 | 27.81 Mn |
| Jun 30, 2022 | 11.74 Mn |
| Mar 31, 2022 | 17.01 Mn |
| Dec 31, 2021 | 34.46 Mn |
| Sep 30, 2021 | 32.15 Mn |
API Access
Incyte Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();